eyeforpharma Japan 2020 is where you will decide your future. The healthcare landscape is evolving and pharma must evolve with it. That’s why we have ensured that our agenda features great insights on how to achieve high effectiveness with limited time and resources. Sometimes this involves digitizing existing processes, sometimes it involves forming new partnerships and sometimes it requires imaginative new business models. We will also provide great case studies from industry leaders and plenty of networking time.
From the Opening Keynote, focusing on future direction of pharma with cutting-edge case studies, to the practical tracks covering Clinical Innovation, Commercial Excellence, Medical Affairs & RWE, we will deliver a new direction for your planning.
Be part of the movement to evolve Japan’s pharma industry!
Alexandre de Muralt, Representative Director and President, Merck Biopharma Co., Ltd.eyeforpharma Japan is a valuable platform for our industry to network, exchange views and anticipate our industry trends and evolution.
Taro Ueno CEO SUSMED Inc.
Stefan Sakurai President / Japan Representative Director LEO Pharma
Masatsune Okajima President and COO StemRIM
Hiroyuki Yoshihara Representative Director Life Data Initiative, Japan Emeritus Professor Kyoto University and University of Miyazaki, Japan
Eiji Aramaki Associate Professor, PI, Information Science NAIST Graduate School of Science and Technology
Jovelle L. Fernandez Head Japan Medical Office Takeda
Susie Barnes Vice President and Country Medical Director GlaxoSmithKline Japan
Kentaro Kume Head, R&D Partnership Office Asia Pacific Takeda Pharmaceutical Company Limited
David Hernandez Head of Clinical Operations Japan, Global Clinical Operations Merck Biopharma Co., Ltd.
Haider Alleg Global Head of Digital Excellence Ferring Pharmaceuticals
Debraj Dasgupta Operating Officer, Head of Strategy and GTM Planning Division Nippon Boehringer Ingelheim Co., Ltd.
Director, Patient Impact Analysis, Outcome & Evidence,
Corporate affairs, Health & Value Pfizer
Get free access to slides and audio of RWE & Big Data session (key insights from 30+ RWE and data science experts from Europe’s premier pharma conference+ world-class speakers, Worth 60,000 JPY), if you register for eyeforpharma Japan by this Friday, 6th March.
Digital transformation: Transform your business model by ensuring you act decisively on customer insights. Recognize the need to digitize. Focus on value with partnerships that deliver holistic patient outcomes.
Evidence-led leadership: Generate great evidence through data. Ensure its communicated well to improve decision-making, portfolio design, patient recruitment and better, medically-driven content.
Deliver patient value to drive commercial & medical excellence: Prove the authenticity of your medicine and care provision with robust data and a great story for HCPs and patient outcomes.
Make Japan a clinical powerhouse: See how data and digital technology can cut costs and time in clinical development. Drive a more patient-centric approach in development to ensure Japan becomes the world's best place to run innovative clinical trials.
Keynote Get out of your comfort zone and explore the new frontiers of medicine from the ‘digital twin’ to advanced genomics, digital therapeutics, AI and more.
Commercial Excellence A new commercial model is needed to effectively deliver digital transformation. Use technology to provide deeper value to physicians and even patients.
RWE & Medical: Make trust your most important principle by communicating in an authentic, scientific way, backed by evidence. Use RWE to speed development, widen access and boost patient outcomes.
Clinical Innovation: Cut time and cost through new technology, whilst enabling a more patient-centric approach which boosts recruitment and retention. Recognize that smarter clinical trials could unlock a golden era for pharma.
4 business-critical conference streams
eyeforpharma Japan will cover all key topics with four tracks: Keynote, Clinical Innovation, RWE & Medical and Commercial Excellence. Which means you’ll gain insights which will help drive your business.
Network with over 500 attendees in 15+ hours of dedicated networking time, networking events and interactive sessions.
All stakeholders. All functions. 1 Place.
The most cross-functional pharma event in Japan – decision-makers from marketing, commercial, sales, market access, medical affairs, patient engagement, RWE, digital transformation, IT, clinical and more.
The most senior-level pharma event in Japan
You won’t find a better place to meet your peers since over 80% of the pharma attendees are director-level or above.
Find the solution
Sometimes, the best ideas don’t come from the stage. They come from those chance happenings when you join a roundtable or attend a networking evening. eyeforpharma is packed with opportunities for you to connect with prospective collaborators and idea generators.
Drive the future
Experts and thought leaders will share cutting edged case studies. Re-position your strategy and teams aligned to the industry’s next movement.
Jovelle L. Fernandez, MD, PhD, FPOGS, Head, Japan Medical Office, Takeda Pharmaceutical Companyeyeforpharma Japan is a useful platform to be informed about recent trends in pharma industry.
500+ networkers Key decision-makers in Japanese pharma
Total interaction Roundtables, workshops and panel discussions
Other events say they attract senior executives - people with clout, budget, ideas and a mission. We really mean it. 500 of them.
77% of attendees are director-level and above
eyeforpharma Japan attracts a global audience: a variety of job titles, geographies, cultures and opinions create a rich tapestry.
Satoru Noguchi, Ex-executive Pharma and Principal, GlobalMindsetAs times change, eyeforpharma always captures the current and future trends to help us grow our business.
Haider Alleg, Global Head of Digital Excellence / GMO, Ferring International Centereyeforpharma is a thriving community of experts exchanging opinions and finding answers. You will meet peers who understand and will help to propel your ideas forward.
Yasuyuki Katayama, Corporate Officer, Country Medical Director and Head of Medical Japan, Pfizer Japan Inc.eyeforpharma is where leaders gather and find direction, opportunities and partnerships.
Katsunori Ohyama, Director, Severe asthma dedicated sales force, GlaxoSmithKline K.K.eyeforpharma is always at the forefront of the pharma industry’s next movement.
Get in touch with the eyeforpharma team
Paul Simms Chairman
Blair Gottscho VP Operations
Kana Chia Head of Japan
Hiromasa Araki Business Development Executive
Itsumi Nishikawa Project Director
Akari Ueda Project Director, Japan
Ross McMullan Business Development Director